管腔面积指数测定法在喉癌患者中的应用。
Application of tube LAI assay in larynx cancer patients.
作者信息
Hasek M, Holán V, Síbl O, Kousalová M
出版信息
Neoplasma. 1981;28(6):685-8.
PMID:7040994
Abstract
The tube LAI assay was used for long-term follow-up of specific antitumor immunity in larynx cancer patients. A high percentage of patients examined before surgery exhibited positive LAI reactivity, and the success of treatment was reflected in the disappearance of positive LAI reactions. The tube LAI assay may be useful in diagnosing the precancerous states. Finally, positive LAI reactions were observed in hospital staff members exposed to contact with cancer patients over several years.
摘要
采用试管淋巴细胞转化试验（LAI试验）对喉癌患者的特异性抗肿瘤免疫进行长期随访。术前接受检查的患者中，很大比例表现出LAI反应阳性，治疗成功表现为LAI阳性反应消失。试管LAI试验可能有助于诊断癌前状态。最后，在多年来接触癌症患者的医院工作人员中观察到了LAI阳性反应。
相似文献
1
Application of tube LAI assay in larynx cancer patients.管腔面积指数测定法在喉癌患者中的应用。
Neoplasma. 1981;28(6):685-8.
2
Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.采用试管白细胞黏附抑制试验监测喉癌患者的抗肿瘤免疫。
Cancer Res. 1979 Feb;39(2 Pt 2):651-3.
3
Tube LAI assay in diagnosis and monitoring of a cancer disease.管腔LAI检测在癌症疾病的诊断和监测中的应用
Biomedicine. 1981 Dec;35(7-8):207-8.
4
5
[Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Hinyokika Kiyo. 1984 Oct;30(10):1367-77.
6
7
8
9
10
Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Eur J Surg Oncol. 1989 Feb;15(1):17-9.
Zotero 插件